“As we get ready to submit the DeltaWave for FDA 510K Clearance, we have entered into this purchase agreement to secure capital as we move from R&D phase to production, sales, and marketing. This agreement gives us access to capital via equity at market pricing if and when we need it in the future. Separately, we anticipate submitting the 510K filing towards the end of this week or beginning of next week. We remain excited and confident about the future of the DeltaWave mask as well as the next generation masks under development.”
Tom Wood, RemSleep CEO
https://twitter.com/RemsleepInc
PRISM MediaWire - Maximizing Impact. Reaching Millions